Last reviewed · How we verify
NCT02418871
Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) With an Improved Injector System
NA trial testing FluidVision AIOL in Aphakia in 53 participants. Completed in 5 September 2018.
16 March 2016
Quick facts
| Lead sponsor | PowerVision |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 53 |
| Start date | 13 March 2015 |
| Primary completion | 16 March 2016 |
| Estimated completion | 5 September 2018 |
| Sites | 5 locations across South Africa, Hungary |
Drugs / interventions tested
- FluidVision AIOL
- Cataract surgery — full drug profile →
Conditions studied
- Aphakia — all drugs for Aphakia →
Sponsor
PowerVision
Who can join
50 and older, any sex, with Aphakia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the clinical outcomes of an investigational IOL in patients undergoing cataract extraction and intraocular lens implantation using an improved injector system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02418871
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FluidVision AIOL
Trials testing the same drug.
- NCT03508778 — Clinical Evaluation of the FluidVision Accommodation Intraocular Lens (AIOL) · NA · completed
- NCT03925545 — VisiOn Restoration With FluidVisION Accommodating Intraocular Lens (AIOL) · NA · completed
- NCT02049567 — Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) · NA · completed
Other recruiting trials for Aphakia
Currently open trials in the same condition.
- NCT06258707 — Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL · NA · recruiting
Other PowerVision trials
Trials by the same sponsor.
- NCT03508778 — Clinical Evaluation of the FluidVision Accommodation Intraocular Lens (AIOL) · NA · completed
- NCT03925545 — VisiOn Restoration With FluidVisION Accommodating Intraocular Lens (AIOL) · NA · completed
- NCT02049567 — Clinical Evaluation of the FluidVision Accommodating Intraocular Lens (AIOL) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02418871 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PowerVision
- Last refreshed: 21 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02418871.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing